Works matching IS 15228517 AND DT 2018 AND VI 20 AND IP 1
Results: 18
A change at the helm of Neuro-Oncology.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 1, doi. 10.1093/neuonc/nox229
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 10, doi. 10.1093/neuonc/nox224
- Publication type:
- Article
Extent of surgery in low-grade gliomas: an old question in a new context.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 6, doi. 10.1093/neuonc/nox218
- By:
- Publication type:
- Article
Comment on "Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology Committee".
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 143, doi. 10.1093/neuonc/nox194
- By:
- Publication type:
- Article
Control versus cognition: the changing paradigm of adjuvant therapy for resected brain metastasis.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 2, doi. 10.1093/neuonc/nox180
- By:
- Publication type:
- Article
The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 103, doi. 10.1093/neuonc/nox176
- By:
- Publication type:
- Article
Synergy of vaccination and agonist OX40 treatment--toward a mechanism-driven combination of glioma immunotherapy.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 4, doi. 10.1093/neuonc/nox169
- By:
- Publication type:
- Article
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 123, doi. 10.1093/neuonc/nox149
- By:
- Publication type:
- Article
Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 132, doi. 10.1093/neuonc/nox148
- By:
- Publication type:
- Article
Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 113, doi. 10.1093/neuonc/nox144
- By:
- Publication type:
- Article
Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 66, doi. 10.1093/neuonc/nox132
- By:
- Publication type:
- Article
Activation of WEE1 confers resistance to PI3K inhibition in glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 78, doi. 10.1093/neuonc/nox128
- By:
- Publication type:
- Article
Dissecting human gliomas by single-cell RNA sequencing.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 37, doi. 10.1093/neuonc/nox126
- By:
- Publication type:
- Article
Agonist OX40 immunotherapy improves survival in glioma-bearing mice and is complementary with vaccination with irradiated GM-CSF-expressing tumor cells.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 44, doi. 10.1093/neuonc/nox125
- By:
- Publication type:
- Article
CD70, a novel target of CAR T-cell therapy for gliomas.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 55, doi. 10.1093/neuonc/nox116
- By:
- Publication type:
- Article
Neurological complications of new chemotherapy agents.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 24, doi. 10.1093/neuonc/nox115
- By:
- Publication type:
- Article
MerTK as a therapeutic target in glioblastomaas a therapeutic target in glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 92, doi. 10.1093/neuonc/nox111
- By:
- Publication type:
- Article
Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 13, doi. 10.1093/neuonc/nox087
- By:
- Publication type:
- Article